Yes, pilot studies are often required before full Korean medical device registration, especially for innovative or high-risk devices. These studies help assess safety and efficacy, providing essential data for regulatory evaluation. The Ministry of Food and Drug Safety (MFDS) mandates these studies to ensure compliance with Korean regulatory standards.